Back to Search
Start Over
Reduction in the acquisition rate of carbapenem-resistant Acinetobacter baumannii (CRAB) after room privatization in an intensive care unit.
- Source :
-
The Journal of hospital infection [J Hosp Infect] 2022 Mar; Vol. 121, pp. 14-21. Date of Electronic Publication: 2021 Dec 17. - Publication Year :
- 2022
-
Abstract
- Background: Acinetobacter baumannii is one of the major pathogens responsible for healthcare-associated infections, especially in intensive care units (ICUs).<br />Aim: To evaluate the effect of room privatization in an ICU on the acquisition of carbapenem-resistant A. baumannii (CRAB).<br />Methods: Between March and August 2017, a medical ICU was renovated from a multi-bed bay room to single rooms. Acquisition of CRAB was compared between patients admitted to the ICU over 18 months pre-renovation (September 2015 to February 2017) and post-renovation (September 2017 to February 2019). A Cox proportional hazard model was used with adjustment for demographics and comorbidities.<br />Findings: Of the 901 patients, who contributed 8276 patient-days, 95 (10.5%) acquired CRAB during their ICU stay. The CRAB acquisition rate was significantly higher during the pre-renovation period (1.87 per 100 patient-days) than during the post-renovation period (0.39 per 100 patient-days) (P<0.001). In the multi-variable Cox regression model, CRAB acquisition was significantly associated with the presence of a feeding tube (adjusted hazard ratio (aHR), 6.08; 95% confidence interval (CI), 2.46-15.06; P<0.001), continuous renal replacement therapy (aHR, 1.66; 95% CI, 1.09-2.53; P=0.019) and admission after renovation of the ICU to single rooms (aHR, 0.23; 95% CI, 0.12-0.41; P<0.001).<br />Conclusions: Renovation of ICUs to single rooms is an efficient strategy to prevent transmission of multi-drug-resistant organisms and hospital-acquired infections.<br /> (Copyright © 2021 The Healthcare Infection Society. Published by Elsevier Ltd. All rights reserved.)
- Subjects :
- Anti-Bacterial Agents pharmacology
Anti-Bacterial Agents therapeutic use
Carbapenems pharmacology
Humans
Intensive Care Units
Privatization
Acinetobacter Infections drug therapy
Acinetobacter Infections epidemiology
Acinetobacter Infections prevention & control
Acinetobacter baumannii
Cross Infection drug therapy
Cross Infection epidemiology
Cross Infection prevention & control
Subjects
Details
- Language :
- English
- ISSN :
- 1532-2939
- Volume :
- 121
- Database :
- MEDLINE
- Journal :
- The Journal of hospital infection
- Publication Type :
- Academic Journal
- Accession number :
- 34929231
- Full Text :
- https://doi.org/10.1016/j.jhin.2021.12.012